Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B-NHL BFM 04
2005-002345-39Phase 4Active
- Sponsor
- NOPHO NHL-group
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of B-NHL BFM regimen in non-Hodgkin lymphoma (NHL) and acute lymphoblastic leukemia (ALL), sponsored by NOPHO NHL-group. Primary endpoint: Event-free survival. Started Nov 2005; status: active.
02
Drugs
B-NHL BFM regimen
03
Conditions
non-Hodgkin lymphoma (NHL)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2005-002345-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002345-39.